Meatable is a Biotech company. It has raised $95M in total funding. Latest round: Series B. Backed by Agronomics, Invest-NL, BlueYard.
Meatable funding overview
Meatable is a Biotech company. Meatable has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2023. The round record for Meatable runs through 2023; nothing later has been disclosed. Investors on record include Agronomics, Invest-NL, BlueYard, Bridford Group, Milky Way Ventures, DSM Venturing and 1 others. 7 distinct backers are named across the disclosed rounds.
Meatable has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Meatable?
Agronomics, Invest-NL, BlueYard, Bridford Group, Milky Way Ventures, DSM Venturing are named among the investors backing Meatable.
What was the latest Meatable funding round?
The most recent disclosed round is a Series B, announced in August 2023.
Where is Meatable based?
No headquarters location is disclosed for Meatable.
What sector does Meatable operate in?
Meatable is tracked under Biotech, with $95M in disclosed funding.
When did Meatable last raise?
The last disclosed Meatable round closed in August 2023 at Series B.
We update the Meatable record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
